These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Okamura K; Ishizuka A; Siomi H; Siomi MC Genes Dev; 2004 Jul; 18(14):1655-66. PubMed ID: 15231716 [TBL] [Abstract][Full Text] [Related]
6. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects. Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813 [TBL] [Abstract][Full Text] [Related]
7. Dissecting RNA-interference pathway with small molecules. Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509 [TBL] [Abstract][Full Text] [Related]
8. A systematic analysis of the effect of target RNA structure on RNA interference. Westerhout EM; Berkhout B Nucleic Acids Res; 2007; 35(13):4322-30. PubMed ID: 17576691 [TBL] [Abstract][Full Text] [Related]
9. Local RNA target structure influences siRNA efficacy: a systematic global analysis. Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019 [TBL] [Abstract][Full Text] [Related]
10. The impact of target site accessibility on the design of effective siRNAs. Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400 [TBL] [Abstract][Full Text] [Related]
11. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells. Chang C; Hong SW; Dua P; Kim S; Lee DK Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049 [TBL] [Abstract][Full Text] [Related]
13. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand. Yoo JW; Kim S; Lee DK Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261 [TBL] [Abstract][Full Text] [Related]
14. Preferential cleavage of upstream targets in concatenated miRNA/siRNA target sites support a 5'-3' scanning model for RISC target recognition. Zhang M; Zhang C Biochem Biophys Res Commun; 2024 Apr; 703():149662. PubMed ID: 38359613 [TBL] [Abstract][Full Text] [Related]
15. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila. Preall JB; He Z; Gorra JM; Sontheimer EJ Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750 [TBL] [Abstract][Full Text] [Related]
16. RNAi in primary human chondrocytes: efficiencies, kinetics, and non-specific effects of siRNA-mediated gene suppression. Klatt AR; Klinger G; Zech D; Paul-Klausch B; Renno JH; Schmidt J; Malchau G; Wielckens K Biologicals; 2007 Oct; 35(4):321-8. PubMed ID: 17363270 [TBL] [Abstract][Full Text] [Related]
18. Target accessibility dictates the potency of human RISC. Brown KM; Chu CY; Rana TM Nat Struct Mol Biol; 2005 May; 12(5):469-70. PubMed ID: 15852021 [TBL] [Abstract][Full Text] [Related]
19. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493 [TBL] [Abstract][Full Text] [Related]
20. mRNA translation is not a prerequisite for small interfering RNA-mediated mRNA cleavage. Sen GL; Wehrman TS; Blau HM Differentiation; 2005 Jul; 73(6):287-93. PubMed ID: 16138829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]